Your browser is no longer supported. Please, upgrade your browser.
DaVita Inc.
IndexS&P 500 P/E18.43 EPS (ttm)6.66 Insider Own0.40% Shs Outstand109.01M Perf Week1.94%
Market Cap12.99B Forward P/E12.79 EPS next Y9.60 Insider Trans-8.21% Shs Float103.08M Perf Month-1.25%
Income791.10M PEG1.08 EPS next Q2.18 Inst Own92.80% Short Float2.56% Perf Quarter13.97%
Sales11.53B P/S1.13 EPS this Y39.30% Inst Trans-3.28% Short Ratio4.12 Perf Half Y12.45%
Book/sh11.45 P/B10.72 EPS next Y12.35% ROA4.30% Target Price123.71 Perf Year55.48%
Cash/sh8.46 P/C14.51 EPS next 5Y17.09% ROE48.50% 52W Range75.30 - 129.59 Perf YTD4.58%
Dividend- P/FCF11.72 EPS past 5Y38.60% ROI13.60% 52W High-4.61% Beta1.29
Dividend %- Quick Ratio1.60 Sales past 5Y-3.50% Gross Margin31.00% 52W Low64.16% ATR2.18
Employees67000 Current Ratio1.70 Sales Q/Q-0.70% Oper. Margin13.80% RSI (14)59.64 Volatility1.73% 1.67%
OptionableYes Debt/Eq7.21 EPS Q/Q15.20% Profit Margin6.70% Rel Volume0.97 Prev Close122.78
ShortableYes LT Debt/Eq7.07 EarningsApr 29 AMC Payout0.00% Avg Volume640.94K Price123.61
Recom2.90 SMA202.01% SMA504.43% SMA20015.31% Volume621,619 Change0.68%
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Jan-24-20Upgrade Goldman Neutral → Buy $72 → $97
Nov-07-19Downgrade Raymond James Outperform → Mkt Perform
Oct-25-19Downgrade Wolfe Research Outperform → Peer Perform
Sep-11-19Downgrade William Blair Outperform → Mkt Perform
Jul-26-19Downgrade Robert W. Baird Outperform → Neutral $70 → $65
Jan-08-19Upgrade UBS Sell → Neutral
Jan-03-19Initiated Deutsche Bank Buy $60
Dec-14-18Initiated Barclays Overweight
Nov-28-18Upgrade Raymond James Mkt Perform → Outperform
Nov-16-18Initiated UBS Sell $64
Nov-08-18Downgrade Raymond James Strong Buy → Mkt Perform
Sep-13-18Upgrade JP Morgan Underweight → Neutral
Jan-04-18Upgrade BofA/Merrill Neutral → Buy
Dec-12-17Upgrade Robert W. Baird Neutral → Outperform $63 → $82
Dec-11-17Upgrade Citigroup Neutral → Buy
Dec-07-17Upgrade Raymond James Outperform → Strong Buy
Nov-08-17Reiterated RBC Capital Mkts Sector Perform $64 → $60
Oct-09-17Downgrade JP Morgan Neutral → Underweight
Jun-17-21 11:45AM  
Jun-14-21 08:37AM  
Jun-11-21 09:06AM  
Jun-10-21 08:04AM  
Jun-08-21 11:46AM  
Jun-07-21 10:29AM  
Jun-04-21 11:40AM  
Jun-02-21 06:07AM  
May-31-21 10:45AM  
May-26-21 08:07AM  
May-19-21 11:40AM  
May-13-21 06:02AM  
May-12-21 11:21AM  
May-10-21 07:35AM  
May-07-21 08:58AM  
Apr-30-21 12:50PM  
Apr-29-21 05:45PM  
Apr-27-21 06:02AM  
Apr-26-21 12:43PM  
Apr-24-21 07:18AM  
Apr-22-21 04:05PM  
Apr-19-21 04:35PM  
Apr-14-21 02:41AM  
Apr-12-21 10:00AM  
Mar-29-21 09:00AM  
Mar-26-21 02:06PM  
Mar-25-21 11:00AM  
Mar-23-21 08:00AM  
Mar-18-21 11:04AM  
Mar-16-21 08:00AM  
Mar-15-21 02:32AM  
Mar-13-21 10:30AM  
Mar-09-21 03:00AM  
Mar-02-21 07:00AM  
Feb-24-21 06:00PM  
Feb-23-21 06:13PM  
Feb-18-21 03:37AM  
Feb-13-21 01:32AM  
Feb-12-21 11:47AM  
Feb-11-21 09:31PM  
Feb-10-21 10:36AM  
Feb-06-21 08:52PM  
Feb-05-21 10:52AM  
Jan-29-21 05:47AM  
Jan-28-21 06:34AM  
Jan-20-21 07:47AM  
Jan-05-21 12:18PM  
Jan-04-21 09:26AM  
Dec-31-20 11:50AM  
Dec-29-20 11:40AM  
Dec-28-20 12:18PM  
Dec-25-20 07:50AM  
Dec-23-20 01:45PM  
Dec-22-20 10:38AM  
Dec-21-20 08:35PM  
Dec-17-20 12:56PM  
Dec-15-20 11:50AM  
Dec-14-20 12:46PM  
Dec-11-20 12:55PM  
Dec-10-20 11:40AM  
Dec-07-20 01:16AM  
Nov-27-20 11:50AM  
Nov-25-20 06:46AM  
Nov-24-20 11:40AM  
Nov-23-20 06:04AM  
Nov-20-20 09:02AM  
Nov-19-20 07:54AM  
Nov-17-20 08:48AM  
Nov-16-20 11:30AM  
Nov-11-20 11:50AM  
Nov-10-20 10:24AM  
Nov-06-20 11:40AM  
Nov-05-20 11:00AM  
Nov-04-20 12:21PM  
Nov-03-20 01:53PM  
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arway Pamela MDirectorMay 24Sale123.1237946,66219,239May 25 05:31 PM
DESOER BARBARA JDirectorMay 13Option Exercise75.775,015379,9875,015May 17 06:25 PM
DESOER BARBARA JDirectorMay 13Sale126.011,920241,9450May 17 06:25 PM
Rodriguez JavierChief Executive OfficerMay 05Option Exercise75.42124,0919,358,943397,716May 05 08:09 PM
NEHRA JOHN MDirectorMay 05Option Exercise75.775,015379,9875,015May 05 08:10 PM
Rodriguez JavierChief Executive OfficerMay 05Sale122.2227,0533,306,548273,625May 05 08:09 PM
HEARTY JAMES OChief Compliance OfficerMay 04Option Exercise75.423,308249,48916,874May 05 08:10 PM
BERG CHARLESDirectorMay 04Option Exercise75.775,015379,98717,463May 05 08:10 PM
HEARTY JAMES OChief Compliance OfficerMay 04Sale121.89884107,74613,566May 05 08:10 PM
BERG CHARLESDirectorMay 04Sale122.521,872229,35712,448May 05 08:10 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 03Option Exercise75.7028,1642,132,01597,694May 04 08:24 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 03Sale118.365,290626,14669,530May 04 08:24 PM
Arway Pamela MDirectorMar 22Sale109.5143647,74619,239Mar 22 07:05 PM
DIAZ PAUL JDirectorNov 30Option Exercise68.7019,3581,329,92318,877Dec 02 06:31 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 30Sale109.7425,0002,743,51542,431Dec 02 06:31 PM
Arway Pamela MDirectorNov 20Sale107.8843046,38819,239Nov 23 07:22 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 18Option Exercise69.9267,1004,691,908132,576Nov 19 07:24 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 17Option Exercise75.4236,4772,751,095121,703Nov 19 07:24 PM
DESOER BARBARA JDirectorNov 17Sale111.001,388154,068430Nov 17 09:17 PM
Arway Pamela MDirectorNov 16Option Exercise68.7019,3581,329,92331,292Nov 17 09:15 PM
Arway Pamela MDirectorNov 16Sale111.637,326817,80119,669Nov 17 09:15 PM
DESOER BARBARA JDirectorNov 11Option Exercise68.173,816260,1533,816Nov 13 06:29 PM
Waters Kathleen AlyceChief Legal OfficerNov 10Sale105.0110,0001,050,12955,874Nov 12 06:17 PM
NEHRA JOHN MDirectorSep 23Buy82.952,500207,3745,500Sep 24 06:22 PM
NEHRA JOHN MDirectorSep 22Buy84.603,000253,8143,000Sep 24 06:22 PM
ZUMWALT LEANNE MGroup VP, Government AffairsSep 18Option Exercise72.6036,9232,680,72051,049Sep 22 07:59 PM
ZUMWALT LEANNE MGroup VP, Government AffairsSep 18Sale88.033,772332,03124,590Sep 22 07:59 PM
WESCHLER, R. TEDMember of 10% owner groupSep 17Sale88.002,000,000176,000,00036,095,570Sep 21 04:38 PM
WESCHLER, R. TEDMember of 10% owner groupSep 17Sale88.00200,00017,600,0001,991,806Sep 21 04:38 PM
Arway Pamela MDirectorAug 24Sale87.0257850,29819,239Aug 25 05:56 PM